Injectable intelligent biogel attacks cancerous tumors in vitro

A new injectable biogel has been found to be effective in delivering anti-cancer agents directly into cancerous tumors and killing them. Read more ...

Researched link walking faster or longer with significant cardiovascular benefits in older adults

In a large prospective community-based study of older Americans, modest physical activity was associated with a lower risk of cardiovascular disease. Read More ...

Cirrus Healthcare Products unveils BMR Barometric Migraine Relief

Cirrus Healthcare Products plans to launch this December a new migraine relief product that aims to reduce the duration, intensity and discomfort of migraine headaches. Read More ...

Researchers identify key molecular players in obesity-associated Type 2 diabetes

There is strong evidence that inflammation promotes obesity-associated Type 2 diabetes and diabetes complications, according to a study by BUSM researchers. Read More ...

Current news

The FDA has given the green light to a new treatment for metastatic squamous non-small cell lung cancer in patients who haven’t received previous treatment.
The American College of Physicians on Tuesday urged clinicians to prescribe generic versions of drugs whenever possible.
A computer model of tuberculosis has shown that prescribing antibiotic doses once or twice a week are more likely to lead to drug-resistant strains than are daily antibiotic regimens
The FDA has approved Opdivo (nivolumab) for patients with metastatic renal cell carcinoma (a type kidney cancer) who have received certain earlier treatment.
Impax Laboratories has received final approval by the U.S. Food and Drug Administration for a generic version of dutasteride capsules, 0.5 mg.
Insulin pens have demonstrated enhancement of the diabetes patient’s lifestyle experiences as well as improvements with clinical outcomes.
Initiation and titration of insulin therapy is an opportunity for pharmacists to collaborate with prescribers.
Each January, the American Diabetes Association publishes its Standards of Care for Diabetes.
Each year, J.D. Power completes a pharmacy study to provide a framework to help pharmacies define where and how customer service experiences can be optimized.
Mylan on Tuesday announced that it had launched its generic of Jazz Pharmaceuticals’ FazaClo (clozapine) orally disintegrating tablets.

CPE Monitor Reminders

As of May 1, 2014, ACPE-accredited CE Providers, such as Drug Store News, may no longer issue statements of credit. All credit awarded by ACPE-accredited providers to pharmacists and pharmacy technicians must be via CPE Monitor. Any statements obtained from the Drug Store News website are no longer valid statements of credit. You MUST obtain your statement of credit from CPE Monitor at

Please be sure that you enter your correct NABP e-PID number in your Drug Store News CE profile. This ensures your CE credit will be transmitted to CPE Monitor so you may receive credit for completed CPE activities. To look up your e-PID number go to the or site and search the system for their NABP e-PID number.